Jennison Associates LLC Sage Therapeutics, Inc. Put Options Transaction History

Jennison Associates LLC

4 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q1 2021 May 11, 2021	SELL	$70.65 - $96.76 $98,910 - $135,464	-1,400 Reduced 1.75%	78,800 $5.9 Million
Q4 2019 Feb 07, 2020	BUY	$60.18 - $154.77 $12,036 - $30,954	200 Added 0.25%	80,200 $5.79 Million
Q3 2019 Nov 08, 2019	SELL	$140.29 - $189.96 $14.4 Million - $19.6 Million	-103,000 Reduced 56.28%	80,000 $11.2 Million
Q3 2017 Nov 03, 2017	BUY	$61.4 - $88.52 $11.2 Million - $16.2 Million	183,000	183,000 $11.4 Million

218

48.2M

854K

195K

Ticker SAGE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 59,422,300
Market Cap $415M
Description
Sage Therapeutics, Inc., a biopharmaceutical company, develops and commercializes medicines to treat central nervous system disorders. Its lead product candidate is ZULRESSO, an intravenous formulation of brexanolone for the treatment of postpartum depression (PPD) in adults. The company's product pipeline also includes zuranolone, a neuroactive...

Get notified when there are updates to the investment portfolio of Jennison Associates LLC, based on Form 13F filings with the SEC.

Stay updated on Jennison Associates LLC with notifications on news.